期刊文献+

转载蛋白E与同型半胱氨酸和胱抑素C联合检测对糖尿病合并血管病变的诊断价值 被引量:4

Clinical diagnostic evaluation of APO-E,Hcy,CysC Joint detection on DM merger vascular lesions
下载PDF
导出
摘要 目的探讨糖尿病(DM)患者转载蛋白E(APO-E)、同型半胱氨酸(Hcy)、胱抑素C(CysC)动态变化与并发血管病变的关系。方法对健康人、无糖尿病的冠心病和脑动脉硬化患者、有糖尿病的冠心病和脑动脉硬化患者进行总循环血红蛋白量(Tch)、三酰甘油(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、APO-E、Hcy、Cy-sC项目的测定。测定仪器为Hitachi7600全自动生化分析仪,试剂、校准品及质控品与测定仪器配套。对影响DM患者合并血管病变的危险因素进行Logistic多元回归分析。结果病变各组TG、LDL、APO-E、Hcy、CysC值差异有统计学意义(P<0.05),其中DM各病变组Hcy、CysC测定值及阳性率与健康对照组比,差异有统计学意义(P<0.05)。结论 TG、LDL、Hcy、CysC是DM患者大血管病变发生的危险因素。 Objective To prove the relationship between dynamic changes of diabetes mellitus(DM) patients' apolipoprotein E(APO-E) ,homocysteine(Hcy) ,Cystatin C(CysC) and concurrent vascular lesions. Methods Quantitative assays of Triglyceride(TG), high density lipoprotein(HDL), low density lipoprotein(LDL), APO-E, Hcy, Cy sC of normal people and patients with coronary heart disease and brain arterial sclerosis with and without diabetes were done. Measuring instruments was HITACHI7600 automatic biochemistry analyzer, reagent calibration product, the quality product were measuring instruments supporting. The impact of DM patients with vascular lesions of the dangerous factors were analyzed for logistic regression analysis,. Results The values of TG,APO, LDL, Hey,APO- E,CysC were statistically significant,among them, the values Hcy, CysC and positive rates had statistically significant difference between in DM group. Conclusion LDL, Hcy,CysC,TG are big happened risk factors in DM patients with vascular lesions.
作者 牛璐璐 王丽
出处 《检验医学与临床》 CAS 2012年第23期2966-2967,共2页 Laboratory Medicine and Clinic
关键词 转载蛋白E 同型半胱氨酸 胱抑素C 糖尿病 apolipoprotein E homoeysteine Cystatin C diabetes mellitus
  • 相关文献

参考文献5

二级参考文献50

  • 1崔玉英,唐朝枢.同型半胱氨酸在心血管疾病发病中的作用及其机制[J].临床内科杂志,2005,22(1):4-6. 被引量:28
  • 2丁国锋,毛艳华,石斗飞,张洁,刘同刚,张蕾.老年高血压并缺血性脑卒中患者血浆同型半胱氨酸变化的临床意义[J].山东医药,2006,46(1):30-31. 被引量:42
  • 3Fujiwara R,Kutsumi Y,Hayashi T,et al.Relation of angiographically defined coronary artery disease and plasma concentration of insulin,lipid,and apolipoprotein in normolipidemic subjects with varying degree of gluclose tolerance[J].Am J Cardiol,1995,75(2):122-126.
  • 4Nygard O,Nordrehaug JE,Refsum H,et al.Plasma homocysteine levels and mortality in patients with coronary artery disease[J].N Engl J Med,1997,337(4):230-236.
  • 5Welch GN,Loscalzo J.Homocysteine and atherothrombosis[J].N EnglJ Med,1998,338(15):1042-1050.
  • 6ALObaidi,Stubbs P,Amersey R,et al.Acute and onvalescent changes in plasma homocysteine concentrations in acute coronary syndromes[J].Heart,2001,85(4):380-384.
  • 7Mayer EL,Robinson K,Jacobsen DW,et al.Low plasma homocysteine levels predict reduced atheroma burden in patients undergoing coronary interventions:Evidence from intravascular ultrasound[J].J Am Coll Cardiol,1995,25(supplement):81A.
  • 8Verhoef P,Kok FJ,Kruyssen DA,et al.Plasma total homocysteine,B vitamins and risk of coronary atherosclerosis[J].Arterioscler Thromb Vasc Biol,1997,17 (5):989-995.
  • 9Fonseca VA, Mudaliar S, Schmidt B, et al. Plasma Homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects[J]. Metabolism,1998,47:686.
  • 10M Emoto,H Tahara, H Kanda, et al. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes[J].Diabetes care,2001,24:533-553.

共引文献30

同被引文献22

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部